Lei Jin

3.6k total citations
78 papers, 2.7k citations indexed

About

Lei Jin is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Lei Jin has authored 78 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Epidemiology and 17 papers in Immunology. Recurrent topics in Lei Jin's work include MicroRNA in disease regulation (14 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). Lei Jin is often cited by papers focused on MicroRNA in disease regulation (14 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). Lei Jin collaborates with scholars based in China, United States and United Kingdom. Lei Jin's co-authors include Zheng Zhang, Junliang Fu, Fu‐Sheng Wang, Ming Shi, Zhengsheng Zou, Ruonan Xu, Ji‐Yuan Zhang, Fang Lin, Chad Whelan and David Meltzer and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Lei Jin

72 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Jin China 25 778 765 680 604 435 78 2.7k
Denis Chatelain France 27 809 1.0× 598 0.8× 365 0.5× 422 0.7× 618 1.4× 173 3.1k
Αthanasia Mouzaki Greece 30 514 0.7× 659 0.9× 237 0.3× 932 1.5× 338 0.8× 128 2.8k
Harry L.A. Janssen Netherlands 37 2.1k 2.7× 812 1.1× 2.0k 3.0× 285 0.5× 246 0.6× 112 3.9k
Alberto Benito Spain 34 1.0k 1.3× 611 0.8× 1.2k 1.8× 366 0.6× 736 1.7× 125 3.3k
Mónica Marazuela Spain 38 922 1.2× 1.1k 1.4× 157 0.2× 1.1k 1.8× 933 2.1× 202 5.2k
Hirayuki Enomoto Japan 34 1.3k 1.7× 1.6k 2.1× 1.3k 1.9× 185 0.3× 514 1.2× 181 4.0k
Akitaka Shibuya Japan 27 1.3k 1.7× 594 0.8× 1.6k 2.3× 306 0.5× 346 0.8× 122 3.1k
Anthony M. Marinaki United Kingdom 32 543 0.7× 916 1.2× 254 0.4× 289 0.5× 349 0.8× 85 3.2k
Stefan Farkas Germany 27 1.0k 1.3× 1.1k 1.5× 1.3k 1.9× 791 1.3× 939 2.2× 82 4.4k

Countries citing papers authored by Lei Jin

Since Specialization
Citations

This map shows the geographic impact of Lei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Jin more than expected).

Fields of papers citing papers by Lei Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Jin. The network helps show where Lei Jin may publish in the future.

Co-authorship network of co-authors of Lei Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Jin. A scholar is included among the top collaborators of Lei Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Jin. Lei Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yijie, et al.. (2024). Impact of Type of Lenvatinib Resistance on Prognosis and Second-Line Regimen in Patients with Virus-Associated HCC. Journal of Hepatocellular Carcinoma. Volume 11. 1507–1517. 3 indexed citations
2.
3.
Luo, Jun, et al.. (2024). Shift in microorganism and functional gene abundance during completely autotrophic nitrogen removal over nitrite (CANON) process. Journal of Environmental Management. 359. 121009–121009. 6 indexed citations
4.
Zhou, Zihan, Lei Jin, Xiaowen Li, et al.. (2023). TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC. Biology Direct. 18(1). 18–18. 24 indexed citations
5.
Jin, Lei, Bowen Chen, Tao Yan, et al.. (2023). Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 357–367. 2 indexed citations
6.
7.
8.
Chen, Bowen, Lei Jin, Haitao Zhao, et al.. (2022). Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study. SHILAP Revista de lepidopterología. Volume 9. 1171–1185. 4 indexed citations
9.
Qu, Wei‐Feng, Pei‐Yun Zhou, Wei‐Ren Liu, et al.. (2020). Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection. Annals of Translational Medicine. 8(7). 487–487. 28 indexed citations
10.
Zhu, Bei, Wei‐xian Chen, Yue Fu, et al.. (2020). <p>MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 6873–6884. 12 indexed citations
11.
Tian, Meng‐Xin, Wei‐Ren Liu, Wei Deng, et al.. (2019). <p>Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma</p>. Cancer Management and Research. Volume 11. 5187–5195. 14 indexed citations
12.
Sun, Mimi, Wei Zhang, Gang Chen, et al.. (2017). IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir. Molecules and Cells. 40(6). 418–425. 17 indexed citations
13.
Lindsay, Robert, John H. Krege, Francisco Marı́n, Lei Jin, & J Štěpán. (2016). Teriparatide for osteoporosis: importance of the full course. Osteoporosis International. 27(8). 2395–2410. 130 indexed citations
14.
Shang, Qinghua, Xinyue Chen, Weimin Nie, et al.. (2015). Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients. Cellular and Molecular Immunology. 12(3). 309–316. 85 indexed citations
15.
Yu, Xue‐Zhong, et al.. (2014). CD152 and PD-1 Down-Regulation on CD8 T Cells Is Associated With Human Acute Liver Allograft Rejection. Transplantation Proceedings. 46(10). 3511–3514. 7 indexed citations
16.
Feng, Guohua, Ji‐Yuan Zhang, Qing‐Lei Zeng, et al.. (2013). HCV-Specific Interleukin-21+CD4+ T Cells Responses Associated with Viral Control through the Modulation of HCV-Specific CD8+ T Cells Function in Chronic Hepatitis C Patients. Molecules and Cells. 36(4). 362–367. 16 indexed citations
17.
Zhang, Zheng, Hu Lin, Ming Shi, et al.. (2012). Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology and Hepatology. 27(s2). 112–120. 273 indexed citations
18.
Shi, Ming, Junliang Fu, Shi Feng, et al.. (2009). Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection. Clinical Immunology. 132(1). 43–54. 20 indexed citations
19.
Zhang, Zheng, Dongping Xu, Yonggang Li, et al.. (2005). Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome. Clinical Immunology. 116(3). 225–235. 18 indexed citations
20.
Skinner, Richard, et al.. (1998). The N‐terminal segment of antithrombin acts as a steric gate for the binding of heparin. Protein Science. 7(3). 782–788. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis Chatelain Breakdown of academic impact, for papers by Αthanasia Mouzaki Breakdown of academic impact, for papers by Harry L.A. Janssen Breakdown of academic impact, for papers by Alberto Benito Breakdown of academic impact, for papers by Mónica Marazuela Breakdown of academic impact, for papers by Hirayuki Enomoto Breakdown of academic impact, for papers by Akitaka Shibuya Breakdown of academic impact, for papers by Anthony M. Marinaki Breakdown of academic impact, for papers by Stefan Farkas
Rankless by CCL
2026